BRIEF published on 06/03/2025 at 17:05, 11 months 9 days ago Evotec SE Annual General Meeting 2025 Highlights Drug Discovery Shareholder Decisions Strategic Outlook Evotec 2025 AGM Board Introductions
PRESS RELEASE published on 06/03/2025 at 17:00, 11 months 9 days ago Evotec SE: Results of the Annual General Meeting 2025 Evotec SE shareholders approve proposals at Annual General Meeting 2025, featuring strategic outlook and new Management Board members; 46.45% share capital represented Annual General Meeting Shareholders Evotec SE Management Board Strategic Outlook
BRIEF published on 05/07/2025 at 07:35, 1 year ago Evotec Secures $2.5 Million Grant for Tuberculosis Treatment Development Evotec Global Health Drug Resistance Tuberculosis Gates Foundation
BRIEF published on 05/07/2025 at 07:35, 1 year ago Evotec obtient une subvention de 2,5 millions de dollars pour le développement d'un traitement contre la tuberculose Evotec Santé Mondiale Résistance Aux Médicaments Tuberculose Fondation Gates
PRESS RELEASE published on 05/07/2025 at 07:30, 1 year ago Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments Evotec SE receives $2.5 m grant from Gates Foundation to develop next-generation tuberculosis treatments, focusing on drug combinations to reduce treatment duration and overcome resistance Evotec SE Grant Gates Foundation Tuberculosis Treatments Drug Combinations
BRIEF published on 05/06/2025 at 07:05, 1 year ago Evotec SE Reports Q1 2025 Financial Results Amid Soft Market Strategic Partnerships Financial Outlook Biologics Growth Protein Degradation Evotec Q1 2025
BRIEF published on 05/06/2025 at 07:05, 1 year ago Evotec SE publie ses résultats financiers du premier trimestre 2025 dans un contexte de marché faible Partenariats Stratégiques Perspectives Financières Croissance Des Produits Biologiques Evotec T1 2025 Dégradation Des Protéines
PRESS RELEASE published on 05/06/2025 at 07:00, 1 year ago Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment Evotec SE reports Q1 2025 results, highlighting strategic partnerships & sustainable growth plans in soft market. 2025 guidance and 2028 outlook confirmed Strategic Partnerships Evotec SE Growth Plans Q1 2025 Soft Market
BRIEF published on 04/29/2025 at 10:07, 1 year ago Evotec SE annoncera ses résultats du premier trimestre 2025 le 6 mai Résultats Financiers Evotec SE Conférence Téléphonique Développement Thérapeutique Détails De La Webdiffusion
BRIEF published on 04/29/2025 at 10:07, 1 year ago Evotec SE to Announce Q1 2025 Results on May 6 Financial Results Conference Call Evotec SE Therapeutics Development Webcast Details
Published on 05/13/2026 at 00:00, 2 hours 26 minutes ago Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Published on 05/12/2026 at 23:35, 2 hours 51 minutes ago Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 4 hours 31 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 4 hours 44 minutes ago Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 11 hours 56 minutes ago Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 23:47, 2 hours 39 minutes ago Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
Published on 05/12/2026 at 22:25, 4 hours 1 minute ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 6 hours 5 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 6 hours 51 minutes ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 6 hours 51 minutes ago 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:15, 8 hours 11 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 8 hours 11 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 8 hours 16 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 8 hours 16 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 8 hours 36 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités
